NCT02454751View on ClinicalTrials.gov

The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

June 30, 2017

Study Completion Date

September 15, 2017

Conditions
DyspneaCongestive Heart Failure
Interventions
DRUG

fentanyl

One time dose of 50mcg of fentanyl administered intranasally

Trial Locations (1)

R2H 2A6

St. Boniface General Hospital, Winnipeg

All Listed Sponsors
lead

St. Boniface Hospital

OTHER

NCT02454751 - The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial | Biotech Hunter | Biotech Hunter